Company registration number 00316674 (England and Wales)
COX AND ROBINSON (CHEMISTS) LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
PAGES FOR FILING WITH REGISTRAR
COX AND ROBINSON (CHEMISTS) LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
COX AND ROBINSON (CHEMISTS) LIMITED
BALANCE SHEET
AS AT 30 NOVEMBER 2025
30 November 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Investments
2
1
1
Current assets
-
-
Creditors: amounts falling due within one year
4
(149,879)
(149,879)
Net current liabilities
(149,879)
(149,879)
Net liabilities
(149,878)
(149,878)
Capital and reserves
Called up share capital
150,000
150,000
Profit and loss reserves
(299,878)
(299,878)
Total equity
(149,878)
(149,878)
For the financial year ended 30 November 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 21 August 2026 and are signed on its behalf by:
Mr P Cattee
Director
Company registration number 00316674 (England and Wales)
COX AND ROBINSON (CHEMISTS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 2 -
1
Accounting policies
Company information
Cox and Robinson (Chemists) Limited is a private company limited by shares incorporated in England and Wales. The registered office is 11 Manchester Road, Walkden, Manchester, M28 3NS.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Profit and loss account
The company has not traded during the year or the preceding financial period. During this time, the company received no income and incurred no expenditure and therefore no Profit and loss account is presented in these financial statements.
1.3
Fixed asset investments
Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.
2
Fixed asset investments
2025
2024
Notes
£
£
Investments in subsidiaries
3
1
1
Movements in fixed asset investments
Shares in subsidiaries
£
Cost or valuation
At 1 December 2024 & 30 November 2025
5,780
Impairment
At 1 December 2024 & 30 November 2025
5,779
Carrying amount
At 30 November 2025
1
At 30 November 2024
1
3
Subsidiaries
Details of the company's subsidiaries at 30 November 2025 are as follows:
COX AND ROBINSON (CHEMISTS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
3
Subsidiaries
(Continued)
- 3 -
Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Cox and Robinson Pharmacy Limited
11 Manchester Road, Walkden, Manchester, M28 3NS
Ordinary
100.00
4
Creditors: amounts falling due within one year
2025
2024
£
£
Other creditors
149,879
149,879
5
Ultimate controlling party
The company's immediate parent is W R Evans Healthcare Limited, incorporated in England and Wales.
The ultimate parent is PCT Healthcare (Holdings) Limited, incorporated in England and Wales.